Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Alette M Wessels
The New England Journal of Medicine
|
August 11, 2021
Donanemab in Early Alzheimer's Disease. Reply
Mark A Mintun, Alette M Wessels, John R Sims
European Journal of Pharmacology
|
April 9, 2008
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes
Alette M Wessels, Philip Scheltens, Frederik Barkhof, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 9, 2022
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates
Alette M Wessels, Dorene M Rentz, Michael Case, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 30, 2022
Disease progression model using the integrated Alzheimer's Disease Rating Scale
Ivelina Gueorguieva, Laiyi Chua, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 10, 2020
Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable
Dorene M Rentz, Alette M Wessels, Lisa J Bain, et al.
Neurology. Clinical Practice
|
March 9, 2023
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings
Alette M Wessels, Ellen B Dennehy, Sherie A Dowsett, et al.
Drug Discovery Today
|
January 24, 2021
Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development
Alette M Wessels, Chris J Edgar, Pradeep J Nathan, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 5, 2025
Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD
Laure Delbecque, Emma Elliott, Sophie Cleanthous, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 26, 2011
Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study
Alette M Wessels, Kathleen A Lane, Sujuan Gao, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Alette M Wessels
The New England Journal of Medicine
|
August 11, 2021
Donanemab in Early Alzheimer's Disease. Reply
Mark A Mintun, Alette M Wessels, John R Sims
European Journal of Pharmacology
|
April 9, 2008
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes
Alette M Wessels, Philip Scheltens, Frederik Barkhof, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 9, 2022
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates
Alette M Wessels, Dorene M Rentz, Michael Case, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 30, 2022
Disease progression model using the integrated Alzheimer's Disease Rating Scale
Ivelina Gueorguieva, Laiyi Chua, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 10, 2020
Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable
Dorene M Rentz, Alette M Wessels, Lisa J Bain, et al.
Neurology. Clinical Practice
|
March 9, 2023
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings
Alette M Wessels, Ellen B Dennehy, Sherie A Dowsett, et al.
Drug Discovery Today
|
January 24, 2021
Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development
Alette M Wessels, Chris J Edgar, Pradeep J Nathan, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 5, 2025
Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD
Laure Delbecque, Emma Elliott, Sophie Cleanthous, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 26, 2011
Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study
Alette M Wessels, Kathleen A Lane, Sujuan Gao, et al.
Page
of 4